Disclosure of Insider Information as per Article 17 of MAR

Wacker Chemie AG / Impairment

WACKER Intends to Take an Impairment on Fixed Assets

Munich, December 5, 2019, 04.30 p.m. CET - In its financial statements for 2019, Wacker Chemie AG intends to take an impairment of around €750 million on the carrying amount of its production facilities for hyperpure polysilicon. The write-down stems from the continued absence of a recovery in solar-grade polysilicon prices due to the high overcapacity created by Chinese manufacturers.

The exact amount to be written down will become clear during the completion of the financial statements. The impairment will reduce not only the value of property, plant and equipment in the consolidated statement of financial position, but also Group EBIT, WACKER POLYSILICON's EBIT, and the Group's net result for the year. Cash flow, on the other hand, will be unaffected by the write-down.

For 2019, WACKER now expects a net result of around €-750 million (previous guidance: slightly positive net income). As previously, today's guidance excludes special income of €112.5 million in insurance compensation, which WACKER booked in Q3 2019.

Issuer and Contact

Wacker Chemie AG
Hanns-Seidel-Platz 4
81737 Munich, Germany
Investor Relations
Joerg Hoffmann
Tel. +49 89 6279 1633
Fax: +49 89 6279-1179
[email protected]
www.wacker.com

Additional Information

ISIN: DE000WCH8881
WKN: WCH888
Deutsche Boerse: WCH
Ticker, Bloomberg: CHM/WCH:GR
Ticker, Reuters: CHE/WCHG.DE
Listing: Frankfurt Stock Exchange (Frankfurter Wertpapierbörse), Official Market (Prime Standard)

Disclaimer
This publication contains forward-looking statements based on assumptions and estimates of WACKER's Executive Board. Although we assume the expectations in these forward-looking statements are realistic, we cannot guarantee they will prove to be correct. The assumptions may harbor risks and uncertainties that may cause the actual figures to differ considerably from the forward-looking statements. Factors that may cause such discrepancies include, among other things, changes in the economic and business environment, variations in exchange and interest rates, the introduction of competing products, lack of acceptance for new products or services, and changes in corporate strategy. WACKER does not plan to update its forward-looking statements, nor does it assume the obligation to do so.

This document includes supplemental financial measures (not clearly defined in the applicable financial reporting framework) that are or may be alternative performance measures (APM). These supplemental financial measures should not be viewed in isolation or as alternatives to measures of WACKER's net assets and financial positions or results of operations as presented in accordance with the applicable financial reporting framework in its Consolidated Financial Statements. Other companies that report or describe similarly titled alternative performance measures may calculate them differently. Explanations of financial measures used can be found in the Annual Report 2018 of Wacker Chemie AG which is available for download under www.wacker.com.